Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Aplindore

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Dopamine replacement therapy in Parkinson’s disease (PD) using l-dopa is invariably associated with a loss of drug efficacy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2009
Review
2009
PD is a neurodegenerative disorder triggered by genetic and/or environmental factors and the pathological processes begin many… Expand
  • figure 1
  • table 1
Is this relevant?
2008
2008
  • 2008
  • Corpus ID: 195105581
 
Is this relevant?
Review
2007
Review
2007
Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders Na Ye,† John L. Neumeyer,‡ Ross J… Expand
  • figure 1
  • table 1
  • figure 3
  • table 2
  • figure 4
Is this relevant?
2006
2006
The pharmacology of aplindore (DAB-452) was characterized in CHO-K1 cells stably transfected with the human dopamine D(2… Expand
Is this relevant?
2006
2006
BACKGROUND AND PURPOSE Low efficacy partial agonists at the D2 dopamine receptor may be useful for treating schizophrenia. In… Expand
Is this relevant?
2004
2004
본 발명은 화학식 I의 화합물 또는 약제학적으로 허용되는 이의 염, 특히 아플린도어의 서방성 투여 제형을 제공한다. 투여형은 특히 이러한 화합물의 투여로부터의 부작용을 경감시키는데 유용하다. 화학식 I… Expand
Is this relevant?